Sharing knowledge and promoting high-quality training are core pillars of IHU RespirERA. In this spirit, Professor Paul Hofman recently represented the institute at a major event for the European medical community: the European School of Pathology (EScoP) course dedicated to thoracic pathology.
Organised by the European Society of Pathology, the three-day event took place in Malaga (Spain) and brought together international experts to explore the latest advances in diagnosing respiratory diseases.
A high-level training programme for European pathologists
The course focused on deepening knowledge related to diseases of the lung, pleura, and thymus. It welcomed both board-certified pathologists and trainees, as well as clinical laboratory scientists.
More than 90 pathologists from across Europe attended the event. The programme, designed to be highly interactive, combined:
- Lectures covering fundamentals and recent diagnostic innovations
- Presentations of real clinical cases
- Q&A sessions and quizzes to encourage active participation
IHU RespirERA among international experts
Professor Paul Hofman’s participation as a member of the teaching faculty reflects the international recognition of IHU RespirERA in the field of thoracic pathology. He delivered his course alongside leading experts such as Jan van Thusen and Teodora Radonic (Netherlands) and Anja Roden (Mayo Clinic Rochester, USA).
Together, they addressed current diagnostic challenges that are essential for guiding patients toward the most appropriate care pathways, particularly in the context of screening and treating thoracic cancers.
Why does this matter for respiratory health?
Pathology plays a central role in medicine: analysing tissue samples provides precise information on the type of disease, its progression, and its biomarkers. By training specialists across Europe in advanced diagnostic techniques, clinical practices become more consistent, ensuring that patients receive accurate and reliable diagnoses wherever they are.
This contribution perfectly aligns with IHU RespirERA’s ambition: reducing the burden of respiratory diseases through research, patient care, and the global sharing of knowledge.
